Qiao R, Deng Y, Zhang S, Wolosker MB, Zhu Q, Ren H, et al
While we used a 12-month period to identify incident patients, it is possible that some people were not true incident patients but had a longer interruption in treatment
Its common for people with PMOS to also have insulin resistance, which can develop into Type 2 diabetes
Catch up: My GLP-1 journey so far A roundup of my articles on weight loss, side effects, and life on Mounjaro Its been a strange old week and I keep trying to write a new article about my experience with Mounjaro, but the words just arent flowing right now
The weight gain from the insulin and the weight loss from the GLP-1 essentially cancel each other out